Clinical trial

EPICO: (Study for the Pro-resolution of Chronic Inflammation in Obesity. Original Acronym From Spanish)

NCT05068557

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DIETARY_SUPPLEMENT · Unmapped registry intervention Dietary plan along with fish oil capsules (3 capsules daily. Containing EPA+DHA: 1.8 g). Find medicine records · Find other trials using this name

DIETARY_SUPPLEMENT · Unmapped registry intervention Dietary plan along with chia/linseed oil capsules (3 capsules daily. Containing ALA 1.6 g). Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

EPICO: (Study for the Pro-resolution of Chronic Inflammation in Obesity. Original Acronym From Spanish)

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-09-24

PhaseNA

Conditions

Obesityverified · MONDO: obesity disorder

Chronic Inflammationunresolved

Interventions

Dietary plan along with fish oil capsules (3 capsules daily. Containing EPA+DHA: 1.8 g).DIETARY_SUPPLEMENT

Dietary plan along with chia/linseed oil capsules (3 capsules daily. Containing ALA 1.6 g).DIETARY_SUPPLEMENT

Sponsors & collaborators

University of Guadalajaralead sponsor

Mapped research locations

GuadalajaraJalisco, Mexico1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05068557 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.